| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/24/2011 | CA2401604C Method of treating cancer with anti-neurotrophin agents |
| 05/24/2011 | CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby |
| 05/24/2011 | CA2345277C Methods for isolation, quantification, characterization and modulation of antigen-specific t cells |
| 05/24/2011 | CA2345201C Mature protein having antagonistic activity against bone morphogenetic protein |
| 05/24/2011 | CA2341642C Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
| 05/24/2011 | CA2337754C Recombinant multivalent malarial vaccine against plasmodium falciparum |
| 05/24/2011 | CA2323072C Gfr.alpha.3 and its uses |
| 05/24/2011 | CA2319310C Equine fc epsilon receptor alpha chain nucleic acid molecules, corresponding proteins and uses thereof |
| 05/24/2011 | CA2270913C Human tumor necrosis factor receptor-like 2 |
| 05/24/2011 | CA2266640C Methods for treating an ischemic disorder and improving stroke outcome |
| 05/24/2011 | CA2264258C Novel antimicrobial peptide |
| 05/24/2011 | CA2247067C Meltrins |
| 05/24/2011 | CA2211687C Vascular endothelial growth factor-b |
| 05/24/2011 | CA2184890C Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c virus |
| 05/24/2011 | CA2133409C Method for in vitro proliferation of dendritic cell precursors and their use to produce immunogens |
| 05/24/2011 | CA1341614C Targeted multifuncional proteins |
| 05/19/2011 | WO2011060218A1 Modulated programmed death ligand-1 |
| 05/19/2011 | WO2011059329A2 Novel pentose transporters and uses thereof |
| 05/19/2011 | WO2011059314A1 Pentose transporters and uses thereof |
| 05/19/2011 | WO2011059092A1 Transformant which produces collagen wherein both lysine residue and proline residue are hydroxylated |
| 05/19/2011 | WO2011059051A1 Flowering inducer |
| 05/19/2011 | WO2011058368A1 Immune system modulating composition |
| 05/19/2011 | WO2011058302A1 Bacteremia-associated antigen from staphylococcus aureus |
| 05/19/2011 | WO2011058286A1 Method for purifying factor b |
| 05/19/2011 | WO2011058285A1 Method for manufacturing a factor h preparation |
| 05/19/2011 | WO2011058284A1 Preparation of a factor h concentrate |
| 05/19/2011 | WO2011058280A1 Human fertility test using dpy19l2 |
| 05/19/2011 | WO2011058188A1 Compounds and methods for purifying peptides produced by solid phase peptide synthesis |
| 05/19/2011 | WO2011058165A1 Long-acting y2 receptor agonists |
| 05/19/2011 | WO2011058137A1 The use of an l3 and/or l5 source as a vaccine or as a diagnostic for a parasitic disease |
| 05/19/2011 | WO2011058055A1 Anti-trypanosome therapeutic and diagnostic applications |
| 05/19/2011 | WO2011058029A1 Plants having enhanced yield-related traits and a method for making the same |
| 05/19/2011 | WO2011057871A2 Use of a protein homologous to a meab protein for increasing the enzymatic activity of a 3-hydroxycarboxylic acid-coa mutase |
| 05/19/2011 | WO2011057788A1 Antibodies specific for claudin 6 (cldn6) |
| 05/19/2011 | WO2011057408A1 Protein concentrates and isolates, and processes for the production thereof |
| 05/19/2011 | WO2011057407A1 Protein concentrates and isolates, and processes for the production thereof from toasted oilseed meal |
| 05/19/2011 | WO2011057336A1 Antibiofilm glycopeptides |
| 05/19/2011 | WO2011057326A1 Method of treatment of type 2 diabetes |
| 05/19/2011 | WO2011036563A3 Structure of the n-rna complex of the non-segmented negative-strand rna viruses of the paramyxoviridae family |
| 05/19/2011 | WO2011008502A3 Isolation of unknown rearranged t-cell receptors from single cells |
| 05/19/2011 | WO2011006072A3 Cardioprotective role of hepatic cells and hepatocyte secretory factors in myocardial ischemia |
| 05/19/2011 | WO2010140060A3 Relaxin peptide synthesis |
| 05/19/2011 | WO2010128407A3 Anti-il-17f antibodies and methods of use thereof |
| 05/19/2011 | WO2010070380A3 Doc1 compositions and methods for treating cancer |
| 05/19/2011 | US20110119791 Isolated polypeptides, polynucleotides useful for modifying water user efficiency, fertilizer use efficiency, biotic/abiotic stress tolerance, yield and biomass in plants |
| 05/19/2011 | US20110119790 Gene Participating in Low Temperature Germinability in Rice and Utilization of the Same |
| 05/19/2011 | US20110118825 Anti-angiogenic compositions and methods of use |
| 05/19/2011 | US20110118451 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 05/19/2011 | US20110118449 Ferritin 2 for the host immunization against ticks |
| 05/19/2011 | US20110118448 Purification of pegylated polypeptides |
| 05/19/2011 | US20110118445 Inhibitor protein of the wnt signal pathway |
| 05/19/2011 | US20110118439 Three-Dimensional Structure Of The Amyloid Precursor Protein Intracellular Domain (AICD) In Complex With Human FE65-PTB2 |
| 05/19/2011 | US20110118438 Cyanine-type compounds having an alkynyl linker arm |
| 05/19/2011 | US20110118364 Pharmaceutical compositions of nanoparticles containing active ingredients |
| 05/19/2011 | US20110118194 Therapeutic Use of LPI, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory Diseases |
| 05/19/2011 | US20110118193 Treatment of liquid cancers |
| 05/19/2011 | US20110118190 Postsynaptically Targeted Chemodenervation Agents and Their Methods of Use |
| 05/19/2011 | US20110118188 Factor viii polypeptide having factor viii:c activity |
| 05/19/2011 | US20110118187 Reversible platelet inhibition |
| 05/19/2011 | US20110118185 Amino acid sequences directed against vascular endothelial growth factor and polypeptides comprising the same for the treatment of conditions and diseases characterized by excessive and/or pathological angiogenesis or neovascularization |
| 05/19/2011 | US20110118183 N-glycosylated human growth hormone with prolonged circulatory half-life |
| 05/19/2011 | US20110118182 Process for the extraction, purification and enzymatic modification of soy 7s globulin alpha' subunit for use as hypocholesterolemizing agent |
| 05/19/2011 | US20110118181 Pcsk9 inhibitors and methods of use thereof |
| 05/19/2011 | US20110118179 Cation complexes of insulin compound conjugates, formulations and uses thereof |
| 05/19/2011 | US20110118144 Engineered phage vectors for the design and the generation of a human non-antibody peptide or protein phage library via fusion to pix of m13 phage |
| 05/19/2011 | US20110118136 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions |
| 05/19/2011 | US20110117661 Polypeptides, systems, and methods useful for detecting glucose |
| 05/19/2011 | US20110117658 Method of rational-based drug design using osteocalcin |
| 05/19/2011 | US20110117644 DR5 gene promoter and SIAH-1 gene promoter |
| 05/19/2011 | US20110117640 Tumor antigens bfa4 and bcy1 for prevention and / or treatment of cancer |
| 05/19/2011 | US20110117626 Hydrophobic Interaction Chromatography Membranes, and Methods of Use Thereof |
| 05/19/2011 | US20110117599 Artificial entropic bristle domain sequences and their use in recombinant protein production |
| 05/19/2011 | US20110117576 Mct-1, a human oncogene |
| 05/19/2011 | US20110117569 Polymide nucleic acid derivatives, and agents and processes for preparing them |
| 05/19/2011 | US20110117558 Diagnosis of hereditary spastic paraplegias (hsp) by identification of a mutation in the zfyve26 gene or protein |
| 05/19/2011 | US20110117556 High-sensitive fluorescent energy transfer assay using fluorescent amino acids and fluoresent proteins |
| 05/19/2011 | US20110117206 Phosphopeptides and use of the same |
| 05/19/2011 | US20110117167 Methods and compositions for soft tissue repair |
| 05/19/2011 | US20110117139 Fully synthetic albumin analog |
| 05/19/2011 | US20110117130 Method of diagnosing and treating Ehrlichia |
| 05/19/2011 | US20110117128 Compositions that Include Hemagglutinin, Methods of Making and Methods of Use Thereof |
| 05/19/2011 | US20110117118 Molecules, compositions, methods and kits for applications associated with flaviviruses |
| 05/19/2011 | US20110117117 Novel immunogenic epitopes for immunotherapy |
| 05/19/2011 | US20110117116 Nucleic acids encoding a house dust mite allergen, der p iii, and uses therefor |
| 05/19/2011 | US20110117115 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders |
| 05/19/2011 | US20110117112 Sodium channel protein type iii alpha-subunit splice variant |
| 05/19/2011 | US20110117109 Cytomegalovirus disintegrin-like peptides |
| 05/19/2011 | US20110117108 Treatment and prevention of cancerous and pre-cancerous conditions of the liver, lung and esophagus |
| 05/19/2011 | US20110117101 Cc chemokine receptor 5 dna, new animal models and therapeutic agents for hiv infection |
| 05/19/2011 | US20110117099 Inhibiting staphylococcus epidermidis infections |
| 05/19/2011 | US20110117096 Methods for Identifying Tumors That are Responsive to Treatement With Anti-ErbB2 Antibodies |
| 05/19/2011 | US20110117095 Growth factor htter36 |
| 05/19/2011 | US20110117082 Soluble Tumor Necrosis Factor Receptor Mutant |
| 05/19/2011 | US20110117017 Peptides with properties of an allosteric antagonist selective for the alpha 1a adrenergic receptor and uses thereof |
| 05/19/2011 | US20110117013 Compositions against cancer antigen liv-1 and uses thereof |
| 05/19/2011 | US20110117012 Radiolabeled gallium complexes, methods for synthesis and use for pet imaging of egfr expression in malignant tumors |
| 05/19/2011 | CA2817495A1 Compositions, methods and uses for stimulating immune responses |
| 05/19/2011 | CA2817082A1 Pentose transporters and uses thereof |
| 05/19/2011 | CA2781045A1 Transformant which produces collagen wherein both lysine residue and proline residue are hydroxylated |
| 05/19/2011 | CA2780763A1 Factor viii b cell epitope variants having reduced immunogenicity |